Clinical Trial Update: An Open Label Study of CM-AT for the Treatment of Children With Autism [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial of CM-AT for autism in children; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• CM-AT

Snippet

Sponsor: Curemark | Conditions: Autism | Phase 3 | Status: ACTIVE_NOT_RECRUITING